Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roy H Perlis

Showing results (91-100 of 414) with videos related to

Pageof 42
Sort By:
JAMA Psychiatry|August 15, 2019
Attention-Deficit/Hyperactivity Disorder, Hypomania, and Bipolar Disorder in YouthLauren V Moran, Perihan Esra Guvenek-Cokol, Roy H Perlis
Neurobiology of Aging|April 11, 2018
Genome-wide association identifies a novel locus for delirium riskThomas H McCoy, Kamber Hart, Amelia Pellegrini, et al.
The American Journal of Psychiatry|June 6, 2018
No Association Between Antidepressant Efficacy and rs28365143 in Corticotropin-Releasing Hormone Binding Protein in a Large Meta-AnalysisChiara Fabbri, Cathryn M Lewis, Roy H Perlis, et al.
Dialogues in Clinical Neuroscience|January 28, 2009
Pharmacogenomic strategy for individualizing antidepressant therapyKeh-Ming Lin, Roy H Perlis, Yu-Jui Yvonne Wan
Psychotherapy and Psychosomatics|August 19, 2007
Antidepressant dose reduction and the risk of relapse in major depressive disorderGeorge I Papakostas, Roy H Perlis, Cheryl Seifert, et al.
The Journal of Pain|July 15, 2010
The association of single nucleotide polymorphisms in the catechol-O-methyltransferase gene and pain scores in female patients with major depressive disorderBonnie Fijal, Roy H Perlis, Alexandra N Heinloth, et al.
The American Journal of Psychiatry|February 2, 2006
Clinical features of bipolar depression versus major depressive disorder in large multicenter trialsRoy H Perlis, Eileen Brown, Robert W Baker, et al.
Journal of Affective Disorders|February 19, 2022
Efficiently identifying individuals at high risk for treatment resistance in major depressive disorder using electronic health recordsIsaac Lage, Thomas H McCoy, Roy H Perlis, et al.
Psychiatric Services (Washington, D.C.)|November 3, 2009
Pharmacogenetics studies in STAR*D: strengths, limitations, and resultsGonzalo Laje, Roy H Perlis, A John Rush, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|June 5, 2009
When is pharmacogenetic testing for antidepressant response ready for the clinic? A cost-effectiveness analysis based on data from the STAR*D studyRoy H Perlis, Amanda Patrick, Jordan W Smoller, et al.
Pageof 42

Showing results (91-100 of 414) with videos related to

Sort By:
Pageof 42
JAMA Psychiatry|August 15, 2019
Attention-Deficit/Hyperactivity Disorder, Hypomania, and Bipolar Disorder in YouthLauren V Moran, Perihan Esra Guvenek-Cokol, Roy H Perlis
Neurobiology of Aging|April 11, 2018
Genome-wide association identifies a novel locus for delirium riskThomas H McCoy, Kamber Hart, Amelia Pellegrini, et al.
The American Journal of Psychiatry|June 6, 2018
No Association Between Antidepressant Efficacy and rs28365143 in Corticotropin-Releasing Hormone Binding Protein in a Large Meta-AnalysisChiara Fabbri, Cathryn M Lewis, Roy H Perlis, et al.
Dialogues in Clinical Neuroscience|January 28, 2009
Pharmacogenomic strategy for individualizing antidepressant therapyKeh-Ming Lin, Roy H Perlis, Yu-Jui Yvonne Wan
Psychotherapy and Psychosomatics|August 19, 2007
Antidepressant dose reduction and the risk of relapse in major depressive disorderGeorge I Papakostas, Roy H Perlis, Cheryl Seifert, et al.
The Journal of Pain|July 15, 2010
The association of single nucleotide polymorphisms in the catechol-O-methyltransferase gene and pain scores in female patients with major depressive disorderBonnie Fijal, Roy H Perlis, Alexandra N Heinloth, et al.
The American Journal of Psychiatry|February 2, 2006
Clinical features of bipolar depression versus major depressive disorder in large multicenter trialsRoy H Perlis, Eileen Brown, Robert W Baker, et al.
Journal of Affective Disorders|February 19, 2022
Efficiently identifying individuals at high risk for treatment resistance in major depressive disorder using electronic health recordsIsaac Lage, Thomas H McCoy, Roy H Perlis, et al.
Psychiatric Services (Washington, D.C.)|November 3, 2009
Pharmacogenetics studies in STAR*D: strengths, limitations, and resultsGonzalo Laje, Roy H Perlis, A John Rush, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|June 5, 2009
When is pharmacogenetic testing for antidepressant response ready for the clinic? A cost-effectiveness analysis based on data from the STAR*D studyRoy H Perlis, Amanda Patrick, Jordan W Smoller, et al.
Pageof 42